Advanced search
1 file | 623.83 KB Add to list

An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity

(2010) CANCER RESEARCH. 70(23). p.9641-9649
Author
Organization
Keywords
SURVIVAL, GENE, EXPRESSION, AMPLIFICATION, POLYMORPHISMS, ACCELERATES TUMOR-FORMATION, P53 PATHWAY, BREAST-CANCER, CARCINOMA, TP53 MUTATION

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 623.83 KB

Citation

Please use this url to cite or link to this publication:

MLA
Wynendaele, Jessica, Anja Böhnke, Eleonora Leucci, et al. “An Illegitimate microRNA Target Site Within the 3’ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity.” CANCER RESEARCH 70.23 (2010): 9641–9649. Print.
APA
Wynendaele, J., Böhnke, A., Leucci, E., Nielsen, S. J., Lambertz, I., Hammer, S., Sbrzesny, N., et al. (2010). An illegitimate microRNA target site within the 3’ UTR of MDM4 affects ovarian cancer progression and chemosensitivity. CANCER RESEARCH, 70(23), 9641–9649.
Chicago author-date
Wynendaele, Jessica, Anja Böhnke, Eleonora Leucci, Søren Jensby Nielsen, Irina Lambertz, Stefanie Hammer, Nadja Sbrzesny, et al. 2010. “An Illegitimate microRNA Target Site Within the 3’ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity.” Cancer Research 70 (23): 9641–9649.
Chicago author-date (all authors)
Wynendaele, Jessica, Anja Böhnke, Eleonora Leucci, Søren Jensby Nielsen, Irina Lambertz, Stefanie Hammer, Nadja Sbrzesny, Dana Kubitza, Anja Wolf, Elise Gradhand, Katharina Balschun, Ioana Braicu, Jalid Sehouli, Silvia Darb-Esfahani, Carsten Denkert, Christoph Thomssen, Steffen Hauptmann, Anders Lund, Jean-Christophe Marine, and Frank Bartel. 2010. “An Illegitimate microRNA Target Site Within the 3’ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity.” Cancer Research 70 (23): 9641–9649.
Vancouver
1.
Wynendaele J, Böhnke A, Leucci E, Nielsen SJ, Lambertz I, Hammer S, et al. An illegitimate microRNA target site within the 3’ UTR of MDM4 affects ovarian cancer progression and chemosensitivity. CANCER RESEARCH. 2010;70(23):9641–9.
IEEE
[1]
J. Wynendaele et al., “An illegitimate microRNA target site within the 3’ UTR of MDM4 affects ovarian cancer progression and chemosensitivity,” CANCER RESEARCH, vol. 70, no. 23, pp. 9641–9649, 2010.
@article{1101085,
  author       = {{Wynendaele, Jessica and Böhnke, Anja and Leucci, Eleonora and Nielsen, Søren Jensby and Lambertz, Irina and Hammer, Stefanie and Sbrzesny, Nadja and Kubitza, Dana and Wolf, Anja and Gradhand, Elise and Balschun, Katharina and Braicu, Ioana and Sehouli, Jalid and Darb-Esfahani, Silvia and Denkert, Carsten and Thomssen, Christoph and Hauptmann, Steffen and Lund, Anders and Marine, Jean-Christophe and Bartel, Frank}},
  issn         = {{0008-5472}},
  journal      = {{CANCER RESEARCH}},
  keywords     = {{SURVIVAL,GENE,EXPRESSION,AMPLIFICATION,POLYMORPHISMS,ACCELERATES TUMOR-FORMATION,P53 PATHWAY,BREAST-CANCER,CARCINOMA,TP53 MUTATION}},
  language     = {{eng}},
  number       = {{23}},
  pages        = {{9641--9649}},
  title        = {{An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity}},
  url          = {{http://dx.doi.org/10.1158/0008-5472.CAN-10-0527}},
  volume       = {{70}},
  year         = {{2010}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: